Table 1.
Concentrations of SCFAs in in-vitro incubation solutions at different time points.
| SCFAs | Samples | Anaerobic incubation time (h) | ||||
|---|---|---|---|---|---|---|
| (mM) | 0 | 3 | 6 | 12 | 24 | |
| Acetate |
Control FHVD |
0.31 ± 0.02 |
0.34 ± 0.10 a 2.35 ± 0.25 b |
1.99 ± 0.40 a 2.69 ± 0.41 b |
2.07 ± 0.28 a 9.13 ± 0.70 b |
5.79 ± 0.11 a 6.40 ± 0.80 b |
| Propionate |
Control FHVD |
0.29 ± 0.02 |
0.51 ± 0.02 a 1.67 ± 0.15 b |
1.36 ± 0.19 a 2.67 ± 0.27 b |
1.26 ± 0.10 a 7.38 ± 0.46 b |
3.40 ± 0.07 a 6.04 ± 0.57 b |
| Butyrate |
Control FHVD |
0.33 ± 0.01 |
0.42 ± 0.02 a 0.88 ± 0.01 b |
0.92 ± 0.06 a 1.59 ± 0.08 b |
1.25 ± 0.10 a 5.54 ± 0.25 b |
2.41 ± 0.02 a 5.46 ± 0.45 b |
Each data was conducted in triplicates, and the value was presented as Mean ± SD. Different lowercase letters indicate significant differences (P < 0.05) among different groups.